Found 8 matching trials
Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement
NAProportional dose of sublingual fentanyl tablet (Narco®) based on daily opi...
Location
Multiple Locations
Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain
PHASE3The purpose of this study was to assess the 90-day safety of fentanyl subli...
Location
Multiple Locations
Conversion From Fast Acting Oral Opioids to Abstral®
PHASE4The purpose of this study is to evaluate safety and efficacy when using a n...
Location
Smärtavdelning B42, Anestesikliniken Karolinska University Hospital, Huddinge
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
PHASE3This is a phase III, randomized, double-blind, placebo-controlled, multicen...
Location
InSys Therapeutics, Incorporated
Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea
PHASE2The goal of this clinical research study is to learn if fentanyl can help s...
Location
University of Texas MD Anderson Cancer Center
The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic Requirements in Spine Surgery Patients
PHASE4In this study the investigators plan to examine the perioperative use of su...
Location
Brigham and Women's Hospital
Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis
PHASE3This was an open-label, single-dose study to assess the safety, tolerabilit...
Location
InSys Therapeutics, Incorporated
Sublingual Fentanyl for the Management of Breakthrough Pain
PHASE2The goal of this clinical research study is to learn if an investigational ...
Location
University of Texas MD Anderson Cancer Center